Por favor, use este identificador para citar o enlazar este ítem:
http://cibnor.repositorioinstitucional.mx/jspui/handle/1001/2534
Alfalfa Plants (Medicago sativa L.) Expressing the 85B (MAP1609c) Antigen of Mycobacterium avium subsp. paratuberculosis Elicit Long‑Lasting Immunity in Mice | |
Elizabeth Monreal Escalante CRISTHIAN FRANCISCO SANDEZ ROBLEDO AMALIA FERNANDA LEON GALLO Virginie Roupie Kris Huygen Sawako Hori-Oshima MARIO ARCE MONTOYA SERGIO ROSALES MENDOZA Carlos Eliud Angulo Valadez | |
Acceso Abierto | |
Atribución-NoComercial-SinDerivadas | |
DOI: 10.1007/s12033-021-00307-w URL: https://link.springer.com/article/10.1007%2Fs12033-021-00307-w ISSN: 1559-0305 | |
Paratuberculosis, 85B antigen, Plant-made vaccine, Alfalfa, Oral vaccine | |
"Mycobacterium avium subsp. paratuberculosis (MAP) is the etiological agent of Paratuberculosis, a contagious, untreatable, and chronic granulomatous enteritis that results in diarrhea, emaciation, and death in farmed ruminants (i.e., cattle, sheep, and goats). In this study, the Ag85B antigen from MAP was expressed in transgenic alfalfa as an attractive vaccine candidate. Agrobacterium-mediated transformation allowed the rescue of 56 putative transformed plants and transgenesis was confrmed in 19 lines by detection of the Ag85B gene (MAP1609c) by PCR. Line number 20 showed the highest Ag85B expression [840 ng Ag85B per gram of dry weight leaf tissue, 0.062% Total Soluble Protein (TSP)]. Antigenicity of the plant-made Ag85B was evidenced by its reactivity with a panel of sera from naturally MAP-infected animals, whereas immunogenicity was assessed in mice immunized by either oral or subcutaneous routes. The plant-made Ag85B antigen elicited humoral responses by the oral route when co-administered with cholera toxin as adjuvant; signifcant levels of anti-85B antibodies were induced in serum (IgG) and feces (IgA). Long-lasting immunity was evidenced at day 180 days post-frst oral immunization. The obtained alfalfa lines expressing Ag85B constitute the frst model of a plant-based vaccine targeting MAP. The initial immunogenicity assessment conducted in this study opens the path for a detailed characterization of the properties of this vaccine candidate." | |
Springer Science | |
2021 | |
Artículo | |
Molecular Biotechnology | |
Inglés | |
VACUNAS | |
Versión publicada | |
publishedVersion - Versión publicada | |
Aparece en las colecciones: | Artículos |
Cargar archivos:
Fichero | Tamaño | Formato | |
---|---|---|---|
Molecular Biotechnology2021.pdf | 76.13 kB | Adobe PDF | Visualizar/Abrir |